Physician profile
Nancy Rivera
NPI 1629360912
$10,886.65
in general payments reported to CMS, 2019-2025
12 companies · $46.56 in 2025
The $46.56 reported for 2025 was less than what a typical Trauma Surgery provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,841 · 2021: $510 · 2022: $89.88 · 2023: $180 · 2024: $219 · 2025: $46.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $446.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $445.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,796.77 | 2019-2023 | Da Vinci Surgical System |
| Tela Bio, INC. | $467.55 | 2021 | |
| Atricure, INC. | $191.27 | 2024 | |
| Medtronic, INC. | $163.39 | 2022-2023 | Sonicision |
| Merck Sharp & Dohme LLC | $116.77 | 2019-2024 | Bridion |
| Kls-Martin L.P. | $26.78 | 2019-2021 | |
| Boston Scientific Corporation | $26.42 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $26.00 | 2025 | |
| Goode Surgical INC | $20.56 | 2025 | |
| Haemonetics Corporation | $20.36 | 2021 | |
| Smith+Nephew, INC. | $17.96 | 2022 | |
| Teleflex LLC | $12.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Rivera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.